Related Experiment Video

Updated: Jul 3, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate

C L Bose1, C E L Dammann, M M Laughon

  • 1Division of Neonatal-Perinatal Medicine, University of North Carolina, Chapel Hill, North Carolina, USA. cbose@med.unc.edu

Archives of Disease in Childhood. Fetal and Neonatal Edition
|August 5, 2008
PubMed

Insights

Inflammation significantly contributes to bronchopulmonary dysplasia (BPD), a common complication in premature infants. Understanding inflammatory biomarkers in airway fluids may help identify infants at risk for BPD.

Area of Science:

  • Neonatal Medicine
  • Pulmonary Medicine
  • Inflammation Research

Background:

  • Bronchopulmonary dysplasia (BPD) is a critical complication of premature birth.
  • Lung inflammation, initiated prenatally and worsened by ventilation and oxygen, drives BPD pathogenesis.
  • A complex interplay of inflammatory mediators, including chemokines, adhesion molecules, and cytokines, contributes to BPD development.

Purpose of the Study:

  • To review the multifaceted role of inflammation in the pathogenesis of bronchopulmonary dysplasia.
  • To explore the involvement of various inflammatory proteins and mediators in BPD development.
  • To discuss the utility of airway fluid biomarkers in understanding BPD and identifying at-risk infants.

Main Methods:

  • Review of existing literature on inflammation and bronchopulmonary dysplasia.
  • Analysis of the roles of chemokines, adhesion molecules, pro-inflammatory and anti-inflammatory cytokines, and proteases.
  • Inclusion of data from biomarker measurements in infant airway fluid samples.

Main Results:

  • Inflammation is a key factor in BPD development, involving a cascade of molecular interactions.
  • Specific proteins facilitate inflammatory cell recruitment, migration, and tissue damage in the lungs.
  • Growth factors and repair mediators also influence lung structure during BPD recovery.
  • Airway fluid biomarker measurements offer insights into inflammatory processes in BPD.

Conclusions:

  • Inflammation is central to the development of bronchopulmonary dysplasia in premature infants.
  • Understanding the inflammatory cascade and utilizing biomarker data can aid in BPD risk identification.
  • Further research into inflammatory pathways may lead to improved prevention and treatment strategies for BPD.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...